The OHDSI Sweden community is building the OMOP data model
The adoption of the OMOP Common Data Model, which aims to harmonise health data, is still at an early stage in Sweden, but progress is rapid.
In 2011 Simo Jääskeläinen was Medaffcon’s first recruitment. A couple of years ago Simo spread his wings to tackle new challenges and further develop his experience in different Market Access positions.
Simo has more than 12 years of experience from the pharmaceutical industry.
Now in June, to our great joy, Simo returned to Medaffcon, taking on the responsibility of leading our Market Access team. We are glad to welcome Simo back “home”!
At Medaffcon, this experience from the pharmaceutical and medtech industries, already exceeds 130 working years, all of which is harnessed to find the best solutions for our customers. Due to our experience and over 400 Medaffcon projects, we understand our customers’ playing field probably better than any of our competitors!

The adoption of the OMOP Common Data Model, which aims to harmonise health data, is still at an early stage in Sweden, but progress is rapid.
Disruption is present in many forms, and our clients are facing new challenges that require them to adapt to new ways of working. The same applies to us.
In a data gap analysis, gaps in the available information of the therapy area and data on a medicinal product are mapped and assessed against regulatory, scientific, and business requirements.